AbstractColorectal cancer is the third most common malignancy in the United States. Improved detection sensitivity of early colorectal neoplasms would have important clinical applications. Herein, we report on using phage display to generate peptide libraries that detect colon carcinoma tissues. To accomplish this, we employed positive selection of a peptide-bearing phage library on poorly differentiated colon carcinoma cells (HT29) and combined this with negative selection of the phage library on well-differentiated colon carcinoma cells (HCT116). Analysis of the resulting library identified a nine-amino-acid, disulfide-constrained peptide, CPIEDRPMC (RPMreI), that stained HT29 colon carcinoma cells. Immunohistochemical staining using FITC...
We developed a screening procedure to identify ligands from a phage display random peptide library t...
There is an urgent need for novel diagnostic methods capable of non-invasive, sensitive and feasible...
Development of peptide-based conjugates for targeted tumour therapy is a current research topic prov...
AbstractColorectal cancer is the third most common malignancy in the United States. Improved detecti...
Colorectal cancer is the third most common malignancy in the United States. Improved detection sensi...
Colorectal cancer is the third most common malig-nancy in the United States. Improved detection sens...
Tumor-targeting therapy can be an efficacious way to cure a malignant tumor in clinical trials. Phag...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
Colorectal cancer (CRC) is a major cause of cancer-related deaths in much of the world. Most CRCs ar...
We developed a screening procedure to identify ligands from a phage display random peptide library t...
There is an urgent need for novel diagnostic methods capable of non-invasive, sensitive and feasible...
Development of peptide-based conjugates for targeted tumour therapy is a current research topic prov...
AbstractColorectal cancer is the third most common malignancy in the United States. Improved detecti...
Colorectal cancer is the third most common malignancy in the United States. Improved detection sensi...
Colorectal cancer is the third most common malig-nancy in the United States. Improved detection sens...
Tumor-targeting therapy can be an efficacious way to cure a malignant tumor in clinical trials. Phag...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
Colorectal cancer (CRC) is a major cause of cancer-related deaths in much of the world. Most CRCs ar...
We developed a screening procedure to identify ligands from a phage display random peptide library t...
There is an urgent need for novel diagnostic methods capable of non-invasive, sensitive and feasible...
Development of peptide-based conjugates for targeted tumour therapy is a current research topic prov...